Trial intelligence / Profile preview

Iron Transfer from SFP-containing Hemodialysate in CKD-HD

NCT01894906Phase 2Completed

Sponsor
Rockwell Medical
Start
Jul 2013
Primary completion
Sep 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of ferric pyrophosphate in chronic kidney disease (CKD), sponsored by Rockwell Medical. Started Jul 2013; status: completed.

02

Drugs

ferric pyrophosphate
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT01894906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01894906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call